Related Experiment Videos
Clinical dose-response studies with guanfacine (BS 100-141), a new antihypertensive agent
Clinical and Experimental Pharmacology & Physiology
|March 1, 1978
Summary
Guanfacine effectively lowers blood pressure in hypertensive patients, with dose-related effects observed between 3-5 mg. This medication may be suitable for twice-daily use, despite causing dry mouth and sedation.
Area of Science:
- Pharmacology
- Cardiovascular Medicine
Background:
- Hypertension is a prevalent cardiovascular condition requiring effective management.
- Guanfacine, a clonidine-like agent, is explored for its antihypertensive properties.
Purpose of the Study:
- To evaluate the effects of single oral doses of guanfacine on blood pressure, pulse rate, salivary flow, and sedation in hypertensive patients.
Main Methods:
- Patients with hypertension received single oral doses of guanfacine (3 mg or 5 mg).
- Measurements of blood pressure, pulse rate, salivary flow, and sedation were recorded at intervals post-administration.
Main Results:
- A dose-related decrease in both lying and standing blood pressure was observed between 2 and 10 hours after guanfacine administration.
- Significant reductions in pulse rate and salivary flow were also noted.
- Sedation was a reported side effect.
Conclusions:
- Guanfacine demonstrates efficacy in lowering blood pressure in hypertensive individuals.
- The drug's profile suggests potential suitability for twice-daily administration.
- Common side effects include xerostomia (dry mouth) and sedation.